S. Jeffrey Hatfield

Affiliations

  • Director at Vir Biotechnology Inc. (VIR), 2023-05-24
  • Director at Viridian Therapeutics Inc. (VRDN), 2021-02-08
  • Director at Atyr Pharma Inc (LIFE), 2020-05-08
  • Chief Executive Officer at Zafgen Inc. (ZFGN), 2019-01-25
  • Director at Invivo Therapeutics Holdings Corp. (NVIV), 2018-01-24
  • Chief Executive Officer at Vitae Pharmaceuticals Inc (VTAE), 2016-10-25
  • Director at Ambit Biosciences Corp (AMBI), 2014-11-12
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VTAE $20.81 50,000 Officer, Director 244,996 2016-09-14 Filing
VTAE $17.00 22,524 Officer, Director 267,360 2015-12-23 Filing